Current Minimal-Invasive and Transcatheter Treatment Developments in Heart Valve Disease
A special issue of Hearts (ISSN 2673-3846).
Deadline for manuscript submissions: closed (15 August 2022) | Viewed by 311
Special Issue Editors
Interests: heart and lung transplantation; aortic valve surgery/experimental; biofluiddynamics/flow simulation; minimal invasive (video-assisted) valve surgery; endovascular aortic therapy; transcatheter heart valve implantation (aortic, mitral)
Special Issues, Collections and Topics in MDPI journals
Interests: acute coronary syndromes; cardiac biomarker research; ischemia/reperfusion injury research; cardio-protection and conditioning; coronary artery bypass grafting; minimal invasive valve surgery; aortic valve surgery; mitral and tricuspid valve repair; transcatheter and endovascular techniques; outcome research; beating heart surgery
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
This Special Issue of Hearts focuses on minimally invasive and transcatheter-based technologies in the treatment of structural heart diseases.
It is a real pleasure to be the guest editor of this Special Issue of Hearts. Over the last 15 years, minimally invasive therapies and concepts have been adopted in the cardiovascular field. This was mainly driven by the introduction of transcatheter aortic valve implantation in 2002. Meanwhile, stent technologies have evolved, port-access surgery or percutaneous mitral valve repair has emerged, and transcatheter aortic repair (TEVAR) has been investigated. As a result, such techniques are routine in modern cardiology and cardiac surgery and are therefore widely used. Thanks to these innovative concepts, even younger and low-risk patients were currently treated by such minimally invasive technologies, which have been initially invented to treat older or high-risk patients.
For example, it is currently estimated that 250,000–300,000 transcatheter aortic valve implantations will be performed worldwide in 2021.
Therefore, the present Special Issue aims to provide the readers with an update in this field of treating structural heart diseases by new innovative concepts.
Prof. Dr. Daniel Wendt
Prof. Dr. Matthias Thielmann
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Hearts is an international peer-reviewed open access quarterly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- transcatheter aortic valve implantation
- transcatheter technologies
- sutureless aortic valve replacement
- minimal-invasive mitral and tricuspid valve procedures
- thoracic endovascular aortic repair
- long-term outcomes of new valve prostheses
- basic knowledge of minimal-invasive technologies
